CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 653079-653183 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/ee0a7632371a08727d41e55aad7d621daeceef7d","sourcedb":"CORD-19","sourceid":"ee0a7632371a08727d41e55aad7d621daeceef7d","text":"In contrast, treatment options for patients with NSCLC and EGFR wild-type (wt), VS-P status are limited.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T94677","span":{"begin":0,"end":104},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T94677","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T90","span":{"begin":0,"end":104},"obj":"Sentence"}],"attributes":[{"subj":"T90","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T1369","span":{"begin":49,"end":54},"obj":"Phenotype"}],"attributes":[{"id":"A1369","pred":"hp_id","subj":"T1369","obj":"http://purl.obolibrary.org/obo/HP_0030358"},{"subj":"T1369","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3109","span":{"begin":49,"end":54},"obj":"Disease"},{"id":"T90954","span":{"begin":49,"end":54},"obj":"Disease"}],"attributes":[{"id":"A3109","pred":"mondo_id","subj":"T3109","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"id":"A63512","pred":"mondo_id","subj":"T90954","obj":"http://purl.obolibrary.org/obo/MONDO_0005233"},{"subj":"T3109","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T90954","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93eca9","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec9396"},{"id":"CORD-19-PD-HP","color":"#93b0ec"},{"id":"CORD-19-PD-MONDO","color":"#caec93"}]}]}}